Search - tctmd.com

Displaying 441 - 460 of 1424

Sort: Relevancy | Date

News Features

Same-Day TAVR: Anomaly or Wave of the Future?

L.A. McKeown

August 27, 2015

News Industry News

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

August 27, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Industry News

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

August 20, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

L.A. McKeown

August 12, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Industry News

Doctor's Best Introduces Two New Heart Health Supplements

August 11, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Opinion Conversations in Cardiology

Conversations in Cardiology: FFR in a Diagnostic-Only Lab and PCI Without On-site Surgery

August 03, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

Advertisement

Same-Day TAVR: Anomaly or Wave of the Future?

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

ILUMIEN I Published: OCT Can Affect PCI Strategy

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Doctor's Best Introduces Two New Heart Health Supplements

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Conversations in Cardiology: FFR in a Diagnostic-Only Lab and PCI Without On-site Surgery

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

Lilly Provides Update on Evacetrapib Phase 3 Trial

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content